site stats

Medilinkthera

Web12 apr. 2024 · SUZHOU, China, April 12, 2024 /PRNewswire/ -- MediLink Therapeutics announced that YL201, the first compound based on MediLink's proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its Phase I first-in … WebDr. Xiao has more than 10 years of biopharmaceutical research experience in academia and industry, responsible for drug discovery, CMC and preclinical research of several …

宜联生物

[email protected] 公司地址 上海子公司 美国子公司 香港子公司 新加坡 大分子研发中心 小分子研发中心 苏州生产中心 苏州行政中心 Web薛彤彤博士拥有十余年生物技术药物、创新小分子药物、adc药物的研发、生产，及国内外合作经验。 管理方面：拥有超过1000人规模团队的管理经验，涵盖大小分子药物设计与筛选、工艺开发与放大、药理毒理研究、临 … jobs in sainsburys near me https://frenchtouchupholstery.com

Medilinkthera at StatsCrop: Medilinkthera.com

Web23 apr. 2024 · 关于宜联生物. 宜联生物是一家新概念抗体药物偶联剂公司，建立了一个差异化的专有肿瘤微环境可激活LINker（TMALIN）ADC技术平台。. 它生产同质的DAR8 ADC产品，有可能解决当前ADC产品的耐药性问题。. 总部位于中国苏州，并在上海和剑桥设立了研发中心。. MediLink ... Web12 apr. 2024 · The company is committed to developing globally competitive conjugated drugs and building a differentiated proprietary ADC technology platform. MediLink … [email protected] Company address Shanghai Subsidiary U.S. subsidiary Hong Kong Subsidiary Singapore Subsidiary Macromolecular R&D Center Micromolecule R&D … jobs in safety and health

苏州宜联生物医药有限公司 - 企查查

Category:宜联生物

Tags:Medilinkthera

Medilinkthera

苏州宜联生物医药有限公司 - 企查查

Web12 apr. 2024 · SUZHOU, China, April 12, 2024 /PRNewswire/ -- MediLink Therapeutics announced that YL201, the first compound based on MediLink's proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its Phase I first-in … WebMEDILINKTHERA is a trademark owned by MediLink Therapeutics(Suzhou)Co.,Ltd. and filed on Monday, March 14, 2024 in the Pharmaceutical Products category. All Names …

Medilinkthera

Did you know?

WebAbout MediLink. Medilink Therapeutics focuses on developing internationally competitive drug conjugates, as well as the latest generation of technologies and products with … [email protected]: 4: first_last: [email protected]: 5: last: [email protected]: Your Questions, Our Answers Get Free Access to MediLink Therapeutics Contacts Info. What is MediLink Therapeutics revenue? MediLink Therapeutics revenue is $24.7 M.

WebFounded on July 08, 2024, MediLink Therapeutics is an innovative drug development company focusing on antibody-drug conjugates (ADC) and related technologies.

Web16 mrt. 2024 · According to ZoomInfo records, Xue Tongtong’s professional experience began in 2024. Since then Xue has changed 2 companies and 2 roles. Currently, Xue Tongtong works as a Chairman, Founder & Chief Executive Officer at … WebWe highly welcome the best talent to join our team to make a difference for the patients around the world

http://iknow.medilinkthera.com/EIP/Knowledge/Show/1043

Web21 jul. 2024 · The domain Medilinkthera.com was registered 1 year ago. The website is ranked #15,933 in the world . Here are more than 23,000 visitors and the pages are … jobs in sa healthWeb群辉NAS客户端备份安装. 软件 - 系统工具. 方法步骤. 1. 客户端下载，安装. Synology Active Backup for Business Agent-2.1.1-1125-x64.msi. 2. 如果以前有安装过，需要退出原有用 … insurrection investgation january 6thWebView Sasha Stann's business profile as Head of Clinical Operations & Project Management Project Lead at MediLink Therapeutics. Find contact's direct phone number, email address, work history, and more. insurrection investigations